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Abstract
Background: The use of small interfering RNAs (siRNAs) to silence target gene expression has
greatly facilitated mammalian genetic analysis by generating loss-of-function mutants. In recent
years, high-throughput, genome-wide screening of siRNA libraries has emerged as a viable
approach. Two different methods have been used to generate short hairpin RNA (shRNA) libraries;
one is to use chemically synthesized oligonucleotides, and the other is to convert complementary
DNAs (cDNAs) into shRNA cassettes enzymatically. The high cost of chemical synthesis and the
low efficiency of the enzymatic approach have hampered the widespread use of screening with
shRNA libraries.
Results: We report here an improved method for constructing genome-wide shRNA libraries
enzymatically. The method includes steps of cDNA fragmentation and endonuclease MmeI
digestion to generate 19-bp fragments, capping the 19-bp cDNA fragments with a hairpin
oligonucleotide, and amplification of the hairpin structures by PCR. The PCR step converts hairpins
into double-stranded DNAs that contain head-to-head cDNA fragments that can be cloned into a
vector downstream of a Pol III promoter.
Conclusion: This method can readily be used to generate shRNA libraries from a small amount
of mRNA and thus can be used to create cell- or tissue-specific libraries.
Background
RNA interference (RNAi) provides a powerful tool for
silencing gene expression. Large-scale phenotypic or path-
way-driven screens of siRNA libraries may help to identify
novel genes that may be targets for therapy in cancer and
other diseases. Two different methods have been used to
construct genome-wide siRNA libraries. One is to chemi-
cally synthesize oligonucleotides based on siRNA design
algorithms (for reviews, see [1,2]). Typically, the oligonu-
cleotides are synthesized in the form of double-stranded
DNA molecules containing short hairpin RNA (shRNA)
templates and are cloned into a Pol III-driven expression
vector. Libraries constructed with this method and target-
ing more than 10,000 different human genes have been
successfully used for screening [3,4]. The other method is
to convert collections of cDNAs into shRNA templates.
Three groups have developed protocols to produce
genome-wide shRNA libraries [5-7]. These protocols share
several common features, and all "measure" the appropri-
ate length of the hairpin using the type IIS restriction
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endonuclease MmeI, which cuts 20/18 nt from its recog-
nition site. The common steps, with minor variations,
include (1) generating random cDNA fragments; (2) ligat-
ing the cDNA fragments with a double-stranded oligonu-
cleotide that contains an MmeI site; (3) restriction
digestion with MmeI; (4) ligating a second oligonucle-
otide to the digested cDNA fragments to form a double-
stranded DNA with a hairpin structure; (5) using a DNA
polymerase with strong strand-displacement activity to
convert the hairpin DNA into double-stranded DNA; and
(6) cloning the double-stranded DNA into an expression
vector.
The chemical synthesis method is a very expensive and
time-consuming approach that requires synthesis of thou-
sands of oligonucleotides, followed by cloning and
sequence validation. Construction of shRNA libraries
from cDNAs provides an economical alternative. How-
ever, the multiple-step process in the current protocols
makes the overall efficiency low and thus requires a large
amount of starting mRNA. To increase the efficiency of
library construction, we have developed an improved
method, which includes newly designed oligonucleotides
and a key PCR step to amplify and convert the hairpin
structures in the abovementioned step 5 into double-
See text for details Figure 1
See text for details. A single G-T mismatched is shown in purple. Restriction enzyme recognition sites are shown in green or 
blue, and sites of cleavage by arrows. The structure of the KSU6 vector is shown in the lower left.BMC Biotechnology 2006, 6:28 http://www.biomedcentral.com/1472-6750/6/28
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Generation of shRNA constructs using YIU Figure 2
Generation of shRNA constructs using YIU. (A) Intermediate products produced during the YIU procedure. Lanes 2 and 
3. The Y oligonucleotide, designed with a single 3' T overhang and therefore unable to self-ligate. Lane 2, without ligase. Lane 3, 
with ligase. Note that the forked shape of the Y oligonucleotide causes abnormal mobility on PAGE. The ligated and MmeI-
digested YI molecules are indicated by an arrowhead in lane 4; the digested YI molecules shift in migration when ligated to the 
U oligonucleotide (arrowhead, lane 5). Note that the YIU molecules are a minor fraction of the product molecules because the 
Y and U oligonucleotides were added at a large molar excess over cDNAs and that the ligation was efficient, as almost all of 
the U oligonucleotides have been converted to dimers. (B) PCR amplification of YIU ligation products. The template used for 
PCR in lane 2 was the PAGE-purified DNA band corresponding to the one labeled with arrowhead in lane 5 of Panel A. The 
template for lane 3 was the whole YIU ligation mixture shown in lane 5 of Panel A. The calculated size of YIU double-stranded 
DNA is 160 bp. (C) Conversion of the X molecule into double-stranded DNA by a "PCR+1" protocol. PCR amplification of 
YIU with 20 cycles results in an extra band (the X molecule) seen in the 200–300 bp region on agarose gels (lane 2). However, 
when the PCR products are diluted with fresh PCR reaction mix (1 × buffer, dNTPs, primers and enzyme) and subjected to 
one additional PCR cycle, the high molecular weight band is lost (lane 3). (D) Scheme of the generation of X molecules. Vent 
polymerase, through its strand-displacement activity, can open hairpin structures to generate fully double-stranded products. 
As the PCR progresses, however, YIU double-stranded DNA molecules accumulate and the concentration of primers 
decreases. When the templates are heat denatured and cooled, two heterogeneous molecules (shown in red or purple) can 
form an X-shaped (cruciform) heterodimer via the common complementary regions (shown in green). (E) Restriction digestion 
of double-stranded DNA of YIU. The YIU double-stranded DNA generated by PCR (the "uncut" lane) is digested with AflII or 
MlyI individually, or in combination to generate suitable inserts for cloning.
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stranded DNAs. The PCR amplification of the hairpin
structures greatly increases the overall efficiency of the
procedure and allows libraries to be constructed from
small amounts mRNA.
Results and discussion
The "YIU" procedure
Fig. 1 outlines our method for converting double-
stranded cDNA into a pool of double-stranded DNA com-
prising a large and diverse population of 19-bp inverted
repeats. The process contains three major steps:
(1) Generation of cDNA hairpins with noncomplemen-
tary ends. In previous reports [5-7], the first oligonucle-
otide used either had a CG overhang or was blunt-ended,
allowing self-ligation. To avoid this problem, the "Y" oli-
gonucleotide was designed with a single 3'-T overhang
(Fig. 1), and thus cannot self-ligate (compare lanes 1 and
2, Fig. 2A). Additional features of the Y oligonucleotide
include (a) an embedded MmeI site, (b) long noncomple-
mentary arms designed for anchoring PCR primers with
high melting temperatures (see below), and (c) a single
basepair mismatch within the 18-bp stem region, result-
ing in the AflII site and MlyI site each being present on
only one arm of the double-stranded PCR products,
allowing the products to be directionally cloned. The unu-
sual shape of the Y oligonucleotide causes abnormal
mobility on PAGE gels (Fig. 2A). Double-stranded cDNA
fragments (the "I") were generated either by restriction
enzyme digestion or by partial DNase I digestion and
repair with T4 polymerase. They were then treated with
Taq DNA polymerase to add a single A at the 3' end [8];
this untemplated addition is reported to occur with an
average efficiency of around 70% [9]. This treatment pre-
vents self-ligation of cDNA fragments but allows them to
ligate to the Y oligonucleotide. Excess "Y" oligonucleotide
was added to increase ligation efficiency.
The ligated "YI" molecule was digested with the restriction
endonuclease MmeI, a Type IIS restriction endonuclease
that cuts 20 and 18 nt away from its recognition site, yield-
ing a 2-nt 3' overhang. A hairpin loop oligonucleotide
("U") with a random 2-nt 3' extension was ligated to the
ends generated by MmeI (Fig. 1). The final product
("YIU") contains a 10-nt loop. In "YIU" molecules, the
cDNA insert is 19 bp in size. Although the U molecules
can ligate to themselves (compare lanes 6 and 7, Fig. 2A),
the U dimers cannot be amplified by PCR.
Because the expected product and several intermediates
migrate anomalously on PAGE gels, the "YIU" ligation
product was identified by excising individual DNA bands
from a PAGE gel and PCR-amplifying extracted DNA. One
band (arrowhead in lane 5, Fig. 2A), presumably contain-
ing the YIU products, gave the maximum yield of the
expected 160-bp PCR product (lane 2, Fig. 2B). Alterna-
tively, the entire ligation mix can be used without purifi-
cation as a template to amplify the 160-bp product (lane
3, Fig. 2B). Thus, it is not necessary to gel-purify the YIU
ligation product before PCR.
(2) PCR amplification of "YIU". Regular DNA hairpins
(consisting only of a stem and loop) cannot be efficiently
PCR-amplified because after the denaturation step, hair-
pins rapidly re-form upon cooling, precluding primer
annealing [10]. However, a DNA hairpin with noncom-
plementary arms, such as YIU molecules, can be effi-
ciently PCR-amplified [11]. Primers corresponding to the
two noncomplementary arms were designed with high
melting temperatures, allowing the annealing and exten-
sion temperature during PCR cycling to be set at 75°C to
destabilize intramolecular hairpins. Vent DNA polymer-
ase was used because of its high fidelity and its strand-dis-
placement activity when at high temperature. Although
hairpins presumably form before primer annealing, Vent
polymerase can open them by strand displacement (Fig.
2D).
In late cycles of PCR amplification, after the denaturation
step, product reannealing competes with primer anneal-
ing. In the case of YIU amplification, after denaturation,
the single-stranded products will form an intramolecular
hairpin. Annealing of two hairpin-containing molecules
with complementary arms yields an "X"-shaped (cruci-
form) product that contains a Holliday junction. Because
in a complex library the two strands comprising the X
almost always will contain different 19-bp inverted
repeats, spontaneous branch migration within the "X"
molecules cannot resolve the Holliday junction to gener-
ate linear molecules (Fig. 2D). At late PCR cycles, the
amplified products consist of a mixture of linear double-
stranded DNA duplexes that migrate at the expected 160-
bp position and these aberrant structures, which migrate
at the 200–300 bp position in agarose gels (lane 1, Fig.
2C, the "X" molecule) and form a smear in PAGE gels
(data not shown). To convert the X molecules to linear
double-stranded DNA, fresh PCR reaction mix (buffer,
dNTPs, primers and polymerase) was added to the PCR
product tube, and an additional PCR cycle was performed
to synthesize the complementary strand for each strand of
the X molecule (lane 2, Fig. 2C). To minimize generation
of the X molecules, the optimal PCR cycle number was
determined by running four PCR reactions with different
cycle numbers. The PCR products were analyzed on agar-
ose gel. With the starting materials used in our experi-
ments, the optimal number of PCR cycles is usually
between 16–18. This cycle number was used in scaling up
the reactions.BMC Biotechnology 2006, 6:28 http://www.biomedcentral.com/1472-6750/6/28
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A. Suppression of EGFP expression by a "YIU" shRNA construct in mouse NIH3T3 cells Figure 3
A. Suppression of EGFP expression by a "YIU" shRNA construct in mouse NIH3T3 cells. This shRNA cassette targets EGFP nt 
243–261, GCACGACTTCTTCAAGTCC, selected as an effective shRNA cassette by a screen described in the text. When 
cotransfected with pEGFP vector at a molar ratio of 3 to 1 (shRNA:pEGFP), GFP fluorescence was suppressed; DsRed2-C1 
was used as an internal control. Images were taken 24 h after transfection. B. Quantitative analysis of suppression efficiency by 
flow cytometry. The shRNA expression vector and the GFP reporter vector pMIG, at a molar ratio of 3 to 1, were cotrans-
fected into mouse NIH3T3 cells. A "classic" shRNA expression construct targeting luciferase was similarly cotransfected in 
control cells. Assays were performed in triplicate at 48 h after transfection. The gate M1 was established using untransfected 
cells. The suppression, as measured by the decrease in mean fluorescence of the gated population, was quantified by flow 
cytometry in triplicate for each sample. Note that this is likely to provide a minimal measure of suppression, as GFP expression 
of many transfected cells may no longer fall within the gate; in fact, the gated population is markedly decreased in cells cotrans-
fected with the shRNA construct targeting EGFP.
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(3) Cloning. The PCR product of YIU was directly digested
with MlyI and AflII in the PCR buffer and separated by
PAGE (Fig. 2E). The 70 bp product band was excised from
gel, purified and directionally cloned into the pKSU6
expression vector.
A. Total RNA isolated from HEK293T cells transfected with either a "classic" or "YIU" construct targeting luciferase was ana- lyzed by Northern blot hybridization to a radioactively labeled luciferase 19-nt sense-strand oligonucleotide and to a 19-nt oli- gonucleotide complementary to 5S RNA Figure 4
A. Total RNA isolated from HEK293T cells transfected with either a "classic" or "YIU" construct targeting luciferase was ana-
lyzed by Northern blot hybridization to a radioactively labeled luciferase 19-nt sense-strand oligonucleotide and to a 19-nt oli-
gonucleotide complementary to 5S RNA. 19- and 27-nt single-stranded DNA oligonucleotides were used as size standards; 
because DNA rather than RNA oligonucleotides were used, the indicated sizes are only approximate. The expected approxi-
mate sizes of the hairpin transcripts are 49 nt ("classic") and 62 nt ("YIU"), whereas both processed forms are expected to be 
~21 nt. B. and C. Constructs expressing luciferase mRNA fused with a fragment of CCND1 mRNA were cotransfected with 
shRNA expression constructs targeting either luciferase or CCND1, as described in Table 1. The negative control shRNA 
expression construct was a "classic" construct targeting BCL2. Samples were analyzed in duplicate, and values were normalized 
using Renilla luciferase expression. Error bars represent the standard deviation. The shRNA constructs targeting CCND1 was 
cotransfected with a luciferase-CCND1 fusion construct containing the target sequence, with the exception of #3, whose target 
sequence is absent from both fusion constructs. Construct #3 thus serves as an additional negative control. The small degree 
of suppression seen with #3 and the apparent small stimulation by some shRNA cassettes may be either due to experimental 
error or to off-target effects of #3 and of the control shRNA construct. The data shown are representative of three individual 
experiments, which all showed similar results.
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Effect of modifications of the U6 promoter and hairpin 
loop on RNAi
The shRNA expression vector pKSU6 contains a modified
human U6 promoter region into which an AflII site was
introduced for ease of cloning (Fig. 1). To test whether our
modifications alter the effectiveness of the resulting shR-
NAs, a small shRNA library was made from EGFP using
DNase I partial digestion and the YIU procedure. Twenty
random clones were tested for shRNA efficiency on 3T3
cells when cotransfected individually with the pEGFP
plasmid and a control plasmid, pDsRed2, expressing Red
Fluorescent Protein (RFP). The fluorescence was exam-
ined 24 h after transfection. One construct showing strong
suppression by fluorescence microscopy (Fig 3A) was fur-
ther analyzed by flow cytometry; in these experiments,
GFP was driven by the LTR promoter of a retroviral vector,
pMIG (MSCV-IRES-GFP). Fig. 3B shows that this shRNA
construct could effectively suppress GFP expression at a
3:1 molar ratio; suppression was an average of 96% in
four individual assays. Therefore, the modifications
appear to adversely affect neither transcription from the
U6 promoter nor subsequent shRNA processing.
To confirm that our modifications do not interfere with
transcription or processing, we prepared three constructs
targeting the same sequence in the luciferase gene
(GTGCGCTGCTGGTGCCAAC), which is known to be an
effective target [7]. The "classic" construct uses a U6 pro-
moter, differing minimally from the U6+1 construct of
Paul et al. [12], and the loop TTCAAGAGA, corresponding
to the earliest generation of shRNA expression cassettes
[13]. The "YIU" construct has the structure generated by
the YIU procedure. In the "miR-30" construct, the target-
ing sequence is engrafted into part of the human micro-
RNA-30a primary transcript sequence, contained in the
pSHAG-MAGIC2 (pSM2) vector [14]. Fig. 4A shows the
results of Northern blot hybridization analyzing cells
transiently transfected with equal amounts of the "classic"
or "YIU" construct targeting luciferase. The two constructs
generated similar quantities of the primary hairpin tran-
script and the processed siRNA. Functional comparison of
the three constructs, as described below, demonstrates
that the "YIU" construct is at least as effective as the other
two constructs in targeting luciferase.
Cloning efficiency and quality of the shRNA library
The model system we chose was the human CCND1 gene,
encoding cyclin D1, which is frequently upregulated in
cancer. This upregulation can occur through gene amplifi-
cation in breast cancer and through a chromosomal trans-
location in mantle cell lymphoma and other B-cell
malignancies. We generated a CCND1 shRNA library and
analyzed random clones for effective RNAi. The full-
length cDNA (4.2 kb) was digested by AluI, DpnI, and
HaeIII, all of which are restriction endonucleases that
yield blunt ends. Digestion with the three restriction
endonucleases generates 54 fragments. Because both ends
of the DNAs can be used for ligation, there are 108 possi-
ble ligation products in total. After cloning into pKSU6,
random bacterial colonies were picked, and PCR was per-
Table 1: CCND1-YIU library.
No. Position Restriction Site Sequence Size (bp) %GC Orient-ation
1 3727–3746 AluI CTCACAGTGCTGTGTGCCCC 20 65 +
2 3497–3516 AluI CTATGGAAGTTGCATAATTA 20 30 +
3 2455–2473 HaeIII GCAGAGGATGTTCATAAGG 19 47 -
4 1692–1711 HaeIII CCACGCTACGCTACTGTAAC 20 55 -
5 1934–1952 HaeIII CTGGTTTTCTACCCAACGG 19 53 +
6 846–864 DpnI TCAAGTGTGACCCAGACTG 19 53 +
7 765–783 HaeIII CCGCAGTGCAAGGCCTGAA 19 58 +
8 594–613 HaeIII CCGCAATGACCCCGCACGAT 20 60 +
9 3318–3336 DpnI TCCCACACAGGCTGGCGGG 19 74 +
10 312–331 DpnI TCGTCGCCACCTGGATGCTG 20 65 +
11 1057–1075 HaeIII CCGGCTCCGCCCTCGCTGC 19 84 -
12 3424–3442 DpnI TCAGATGAAGTGCCCAGCA 19 53 -
13 1804–1822 HaeIII GTAGCAGGGTCGGGAAAGG 19 63 +
14 2970–2988 AluI CTCCATTTTCTTATTGCGC 19 42 +
15 1989–2007 AluI CTACTTGGTTTGTGTTCTT 19 37 +
16 2752–2771 EcoRI AGGGGCAGGGGATAAGAATT 20 50 -
17 359–377 HaeIII CCAGCGGGAAGACCTCCTC 19 68 -
18 1117–1135 AluI TTGATACCAGAAGGGAAAG 19 42 -
19 Recombined LacZ
20 Long CCND1 62
CCND1 sense-strand sequences are shown. Nucleotide numbers correspond to [Genbank:BC023620]. Orientation is denoted "+" or "-" if the 
sequence shown occurs before or after the shRNA loop, respectively.BMC Biotechnology 2006, 6:28 http://www.biomedcentral.com/1472-6750/6/28
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formed to examine the inserts. Out of 95 colonies, 71
(75%) had inserts. Twenty clones were sequenced (Table
1). Eighteen of the twenty clones have hairpin inserts; one
clone yielded only the lacZ gene sequence, implying that
recombination had occurred; and one clone contains a
longer CCND1 fragment. In the 18 clones with hairpins,
the inserts are either 19 or 20 bp, reflecting the variability
in the site of cleavage by the MmeI endonuclease [5]. All
the 18 clones derived from a restriction digestion: 8 clones
from HaeIII, which has the most sites (28 sites) in
CCND1, 5 clones from AluI (17 sites), 4 clones from DpnI
(9 sites), and 1 clone from EcoRI (1 site). The positions of
the inserted sequences were random within CCND1: 5
clones were from nt 1–1000; 6 from nt 1001–2000; 3
from nt 2001–3000; and 4 from nt 3001–4200. Impor-
tantly, the PCR step of the YIU process appears to amplify
all hairpin structures with no apparent bias with respect to
GC content. In the 18 sequenced clones, the percentage of
GC varied between 30% and 84%, with 5 clones (28%)
having less than 50% GC, 6 clones (33%) having 50–60%
GC, and 7 clones (39%) having GC content over 60%.
Therefore, our two-temperature PCR cycle protocol can
amplify a wide range of potential hairpin structures.
Analysis of the CCND1 shRNA library
To demonstrate the utility of this shRNA library construc-
tion method, random clones from the CCND1  shRNA
library were tested for effective RNAi by cotransfection
with one of two constructs expressing luciferase fused in
its 3'UTR to a portion of the CCND1 gene (Fig. 4B and
4C). The shRNA constructs were also compared to three
constructs targeting the luciferase portion of the fusion
transcript. The two CCND1 fragments together comprise
almost the entire CCND1 cDNA with the exception of a
small portion of the 3' UTR containing a cluster of
AUUUA motifs, which are often associated with mRNA
instability [15]. The relatively low level of expression of
the "2.5 kb" construct suggests, however, that this frag-
ment may confer instability of the fusion transcript; this
may result in less apparent further destabilization by the
shRNA expression constructs. A destabilizing region has
been mapped within the sequences contained in the "2.5
kb" construct [16,17]. Notably, the YIU construct target-
ing luciferase was at least as effective as either the "classic"
construct or the construct in which the target is embedded
in a microRNA structure ("miR-30"). Several of the enzy-
matically generated constructs effectively targeted the
fusion transcript. The most effective of the tested clones,
#2, is predicted to be a potentially effective shRNA by
Dharmacon's program [18].
Construction of shRNA libraries is the first step toward the
goal of performing mammalian genome-wide screens
with the RNAi technology. The applications of shRNA
library technology also include determining the best
sequences for inhibition of infection by viruses, such as
HIV [19,20], and identifying the most effective shRNAs
for a single gene.
Given the great amount of work required for a functional
screen, if the construction of an shRNA library becomes
much easier, tissue- or cell-specific shRNA libraries are
preferable to generic synthetic shRNA libraries for the fol-
lowing reasons: (a) Not all genes have been identified.
This is particularly likely to be the case for genes with a
very limited range of tissue expression. Thus, with our cur-
rent state of knowledge, any library prepared by individ-
ual chemical synthesis is necessarily incomplete. (b)
Alternative splice forms of some genes may not be affected
if only one or a few shRNAs are used. (c) Screening only
for genes that are actually expressed in a given tissue
reduces the amount of work required. Normalized, tissue-
specific cDNA libraries from IMAGE collections may be
the most cost-effective source of genome-wide cDNA
libraries for generating shRNA libraries. However, each
laboratory can pursue its specific interests using appropri-
ate tissue-specific shRNA libraries.
A major step in constructing an shRNA library from cDNA
is to normalize the cDNA. A simple cDNA normalization
method has recently been reported [21]. The key compo-
nent in this method is a duplex-specific nuclease (DSN)
from the Kamchakta crab. The DSN preferentially cleaves
double-stranded DNA and DNA in RNA-DNA hybrid
duplexes at 70°C. Using this enzyme, cDNA can be nor-
malized after first-strand cDNA synthesis or after amplify-
ing the cDNA. After heat-denaturation and kinetic
reassociation [22,23], abundant cDNAs reanneal more
rapidly than rare cDNAs and are depleted from the mix-
ture by DSN digestion.
Conclusion
The YIU method allows rapid conversion of cDNAs into
shRNA templates. This method has several advantages
over previous methods [5-7]. Our Y oligonucleotide was
designed with a 3' T overhang to prevent self-ligation. To
allow ligation with the Y oligonucleotide, a single 3' A
overhang is added to cDNA fragments by incubating with
Taq DNA polymerase. To create multiple fragments from
each transcript, cDNAs derived from cells or tissues can be
subjected to either partial DNase I digestion, sonication,
or restriction digestion. A PCR step after generating the
YIU molecules was introduced to amplify the desired
product but not irrelevant byproducts, thereby eliminat-
ing the necessity of multiple PAGE purifications as
described in previous methods [5-7] and greatly simplify-
ing the whole process. The PCR amplification also
increases the overall yield of YIU products and allows the
use of small amounts of starting mRNA. This is expectedBMC Biotechnology 2006, 6:28 http://www.biomedcentral.com/1472-6750/6/28
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to be particularly useful for small number of cells sepa-
rated by FACS or microdissection.
The two-temperature PCR program used a high tempera-
ture (75°C) for a combined annealing and extension step
to destabilize hairpin structures and to promote the
strand-displacement activity of Vent polymerase. This
approach has been used in amplifying DNA with a hairpin
structure [11], and we showed that this method has addi-
tional applications in the siRNA field, such as amplifica-
tion of shRNA expression cassettes. Conventional 3-
temperature PCR cycles promote strand slippage of DNA
polymerase when replicating self-annealing structures
[24,25], including the shRNA hairpin [14], leading to
deletions. Adoption of our PCR program to the applica-
tion may alleviate the problem.
Finally, the YIU method is versatile. If an initial larger
loop is secondarily trimmed using a Type IIS restriction
enzyme, constructs can be produced expressing an shRNA
with a loop of arbitrary sequence [5-7]. In particular, with
minor changes in the Y and U oligonucleotides, one
potentially could prepare shRNA expression libraries in
which the targeting siRNA sequences are engrafted into a
microRNA stem and loop structure. The use of a micro-
RNA stem and loop has been shown to dramatically
increase the efficiency of suppression by an shRNA [14]
and is compatible with Pol II promoters, which are more
diverse and versatile than the Pol III promoters necessary
for expression of "classic" shRNAs.
Methods
Oligonucleotides
The "Y" oligonucleotide pair: Y-Forward: 5'-
AACGACGGCCAGTGAGCGCGCGTAATACGACAACAT-
TCTTGAGTCCAAT-3'. Y-Reverse: 5'-PO4-
GTTGGACTTAAGAATGTTGTGCGCTTGGCGTAATCAT-
GGTCATAGCTGTTTC-3'. The "U" oligonucleotide: 5'-
PO4-TCGGCTCTTCCTGTCAAGCCGANN-3'.
PCR primers. Forward: 5'-CGACGCCCAGT-
GAGCGCGCGTAATACG-3'. Reverse: 5'-
GGAAACAGCTATGACCATGATTACGCCAAGCG-3'.
cDNA fragmentation
Human CCND1, encoding cyclin D1, from the 4.2 kb full-
length cDNA clone MGC:23386 [Genbank:BC023620]
(American Type Culture Collection), used here as an
example, was isolated from vector sequences with EcoRI
and XhoI (yielding 2.7 and 1.5 kb fragments, due to an
internal EcoRI site) and end-blunted with Klenow frag-
ment. The gel-purified CCND1 fragments (about 1 to 1.5
μg) were digested in 1 × ThermoPol buffer (New England
Biolabs, NEB) at 37°C for 1 hour individually with AluI,
DpnI and HaeIII, restriction endonucleases with a 4-bp
recognition sequence and blunt-end products. Concen-
trated dNTPs (final 200 μM each) and Taq polymerase (1
U) were added into each tube and incubated at 60°C for
3 hours. After combining the three samples, DNA was
extracted with phenol/chloroform, precipitated by etha-
nol, and resuspended in 10 μl of H2O (about 0.3 μg/μl).
The EGFP gene was PCR-amplified from plasmid pEGFP-
C2 (BD Clontech) using Taq  DNA polymerase (NEB).
After PCR, 1 M Tris-HCl, pH 7.0, and 0.1 M MnCl2 were
added to final concentrations of 40 mM and 1 mM,
respectively. Partial digestion with DNase I (0.1 U in 50
μl) was performed at room temperature for several time
periods (2 to 10 minutes) to determine the optimal diges-
tion time. The partially digested DNA samples were
extracted with phenol/chloroform and precipitated with
ethanol. DNA end-repair with T4 DNA polymerase (NEB)
was conducted following the manufacturer's protocol.
The addition of a 3' A overhang was described above.
The "YIU" procedure
(1) "YI" ligation. Three μl of digested DNA (about 0.9 μg,
the "I" molecule, shown in red in Fig. 1) was mixed with
1 μl of 10 × NEB buffer 4, 1 μl of 0.1 M DTT, 1 μl of 10
mM rATP, 3 μl of 10 μM "Y" paired oligonucleotide and 1
μl T4 DNA ligase (2,000 NEB units, New England Biolabs)
and placed in a thermocycler overnight, cycling between
10°C for 30 sec and 30°C for 30 sec [26]. The T4 DNA
ligase was inactivated at 65°C for 20 min.
(2) MmeI digestion. 1.5 μl of 1 mM S-adenosylmethio-
nine (SAM),1 μl MmeI (2 U, NEB), 1 μl of 10 × NEB buffer
4, and 6.5 μl of water were added to the YI ligation mix
(final 20 μl in volume), and incubated at 37°C for 1 hour.
(3)  YI and "U" ligation. The MmeI-digested DNA was
extracted with phenol/chloroform, precipitated with eth-
anol, and resuspended in 30 μl of water. Four μl of 10 ×
T4 DNA ligase buffer, 5 μl of "U" oligonucleotide (10
μM), and 1 μl T4 ligase (400 NEB Units) were added, and
the mixture incubated in a thermocycler overnight,
cycling between 10°C for 30 sec and 30°C for 30 sec.
(4) PCR amplification. To determine the optimal number
of PCR cycles, four tubes were prepared, each containing
1 μl of the YIU ligation product, 1 unit of Vent DNA
polymerase (NEB) and 1 × buffer, 200 μM dNTPs and 0.5
μM of primers (final conc.) in 50 μl of volume. PCR was
carried out with the following cycling parameters: 95°C
for 2 min, 95°C for 30 sec, 75°C for 1 min, for 15, 17, 19,
or 21 cycles. After PCR amplification, the products were
separated by 1.5% agarose gel electrophoresis. The band
patterns from the four samples were compared, and the
cycle number yielding the greatest quantity of the 160 bp
product was chosen for amplifying a larger quantity forBMC Biotechnology 2006, 6:28 http://www.biomedcentral.com/1472-6750/6/28
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cloning. After the PCR, an equal volume of fresh PCR reac-
tion mix (buffer, dNTPs, primers and polymerase) was
added, and one additional cycle was performed.
(5)  Cloning. Restriction endonucleases AflII and MlyI
were added directly to the PCR product and incubated at
37°C for 2 hours. The 70 bp insert was separated on a
12% polyacrylamide-TBE gel, purified, and cloned into
the expression vector pKSU6.
The shRNA expression vector pKSU6
The U6 promoter was PCR amplified from vector
pAVU6+27 [12] with primers 5'-GGAAGATCTGAGGAG-
GGCCTATTTCCCATG-3' (forward) and 5'-CCGGAATTC-
CTTAAGTTCCACAAGATATATAACTCTATC-3' (reverse).
The PCR product was digested with BglII and EcoRI and
inserted into the BamHI-EcoRI sites in pBluescript II KS+
(Stratagene). An XcmI site was introduced downstream of
the AflII site. The Pol III transcription termination signal
(T5) was embedded in the XcmI site
(CCAAAAATTTTTTGG). The resulting vector, pKSU6, was
cut with XcmI, blunt-ended with T4 DNA polymerase,
and subsequently cut with AflII for cloning AflII-MlyI
digested YIU products. The ligated products were trans-
formed into E. coli XL-10 competent cells (Stratagene).
Control constructs targeting luciferase
The "YIU" construct targeting luciferase was generated by
preparing the KSU6 vector as described above and cloning
into it a double-stranded oligonucleotide prepared by
annealing the oligonucleotide 5'-ttaaGTCCAACTGT-
GCGCTGCTGGTGCCAACTCGGCTTGACAGGAA-
GAGCCGAGTTGGCACCAGCAGCGCAC-3' and its
complement (without ttaa). The U6 promoter of
pBtU6+27 [12] was amplified using the following prim-
ers: 5'-CCGCGGTACCCCGGGAGATCCAAGGTCG-
GGCAG-3' (forward) and 5'-
CGCGTCTAGACCCATCGATGAGGATCCCTTTCCACAA-
GATATATAAAGCC-3' (reverse). The PCR product was
digested with KpnI and XbaI and cloned into the corre-
sponding sites of pBtU6+27. The resulting construct, pU6-
ClaI, is similar to pKSU6, but contains BamHI and ClaI
cloning sites at the 3' end of the U6 promoter. The oligo-
nucleotide 5'-cgTGCGCTGCTGGTGCCAACTTCAAGA-
GAGTTGGCACCAGCAGCGCACTTTTT-3' and its
complement (with 5' ctag, and lacking 3' cg) were
annealed and cloned into the ClaI and XbaI sites to yield
the "classic" construct targeting luciferase. The "miR-30"
construct was prepared by PCR amplification using prim-
ers 5'-CAGAGGCTCGAGAAGGTATATTGCTGTT-
GACAGTGAGCG-3' and 5'-
CTAAAGTAGCCCCTTGAATTCCGAGGCAGTAGGCA-3'
and template 5'-
TGCTGTTGACAGTGAGCGAGGTTGGCACCAGCAGCGC
ACTTAGTGAAGCCACAGATGTAAGTGCGTTGTTGGTGT-
CAATCCTGCCTACTGCCTCGGA-3', essentially as
described [14]. The product was digested with XhoI and
EcoRI and cloned into the corresponding sites of the
pSM2 vector (Open Biosystems).
Cyclin D1 (CCND1) reporter vector preparation
pGL3 Promoter construct (Invitrogen) was modified by
inserting into the XbaI site a double-stranded oligonucle-
otide prepared by annealing the following two oligonu-
cleotides: 5'-ctagGAATTCGATATCCCGCGGCATATGT-3'
(forward) and 5'-ctagACATATGCCGCGGGATATC-
GAATTC-3'. A construct with the insert in the forward ori-
entation was denoted pGL3P(2MCS), having a second
multiple cloning site within the 3'UTR of luciferase. Frag-
ments of CCND1 were inserted into this second multiple
cloning site. Construct luc-CCND1(2.5 kb) was prepared
in several steps, including deletion of a BstXI fragment,
removing approximately 1.6 kb of 3' sequence; it includes
nt 1–2173 [Genbank:BC023620] of CCND1  and addi-
tional 3' sequences. Construct luc-CCND1(1.4 kb) was
prepared by cloning an EcoRI-XbaI fragment of CCND1
(nt 2750–4197) into the corresponding sites of
pGL3P(2MCS). These two reporter constructs were cho-
sen to avoid a cluster of AUUUA sequences, which in
some mRNAs are associated with mRNA instability [15].
Cell culture and transfection
Human HEK293T or mouse NIH3T3 cells were used for
RNAi assays. The cells were seeded 24 hours before trans-
fection in DMEM plus 10% FCS in 96-well plates at 50–
70% confluence. Transfection was conducted with Lipo-
fectamine 2000 (Invitrogen) according to the manufac-
turer's recommendations. The amounts of DNA used per
well were as follows: the reporter plasmid, pEGFP, 50 ng;
Red Fluorescent Protein vector (pDsRed2, Clontech), 50
ng; and shRNA expression vector, 100 ng (~3 × molar
ratio).
Northern blot hybridization
Hybridization was performed as previously described
[27], with minor modifications. HEK293T cells were tran-
siently transfected with either the "classic" or "YIU"
shRNA construct targeting luciferase; total RNA was
extracted with Trizol reagent. 40 μg of total RNA was elec-
trophoresed on a 15% polyacrylamide gene in TBE buffer
(89 mM Tris-borate, 2 mM EDTA) with 8 M urea. RNA was
transferred to GeneScreen Plus membrane (PerkinElmer)
with a semidry electrophoretic transfer apparatus and UV-
crosslinking with 1000 μJ in a Stratagene UV Crosslinker.
StarFire™ template probes (Integrated DNA Technologies,
IDT) contained the following sequences: targeting luci-
ferase, 5'-GTGCGCTGCTGGTGCCAAC-3', and 5S RNA,
5'-GACGAGATCGGGCGCGTTC-3'. Probes were labeled
with [α-32P]-dATP using the Nucleic Acids Labeling Sys-
tem kit (IDT), following the manufacturer's protocol. TheBMC Biotechnology 2006, 6:28 http://www.biomedcentral.com/1472-6750/6/28
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membrane was prehybridized in 0.5 M sodium phosphate
buffer, pH 7.0, 1 mM EDTA, 7% SDS, 0.5% (w/v) sodium
pyrophosphate at 37°C. Approximately 1.7 × 106 dpm of
the luciferase probe and 4 × 105 dpm of the 5S RNA probe
were added to 2 ml of hybridization buffer. After hybridi-
zation at 37°C for ~15 h, the blot was washed 3 × with 2
× SSPE (2 × buffer, 0.3 M NaCl, 20 mM sodium phos-
phate, pH 7.4, 2 mM EDTA), 0.1% SDS 30 min each at
37°C and then exposed overnight to X-ray film.
Luciferase assays
HEK293 cells in 24-well plates were cotransfected with
300 ng Luc-CCND1  reporter plasmid, 900 ng shRNA
expression plasmid, and 20 ng pRL-TK (Renilla luciferase
control). Samples were extracted 48 h after transfection
and analyzed using the Dual-Luciferase Reporter Assay
System (Promega), according to the manufacturer's proto-
col.
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